Sitemap | Contact Us  

Welcome To Taj Pharmaceuticals Ltd API      

About Worldwide  |     FAQs    |    Careers     | |        Media Center  |  |    Taj Pharmaceuticals  World   | |     TAJ Group 


      © 2004 - 2009 Taj Pharmaceuticals Limited . All rights reserved

Granisetron-Hcl_top

      India              Latin America/ Caribbean            Africa & Middle East              Asia              Russia              Europe  

Granisetron Hcl Manufacturers in India Suppliers Granisetron Hcl Dossage Exporters Distributors Granisetron Hcl api active pharmaceuticals ingredients Granisetron Hcl manufacturers Side Effects bulk drugs raw material Dossage Granisetron Hcl companies Side Effects Dossage Importers Granisetron Hcl Dossage Granisetron Hcl Exporters Granisetron Hcl exporters Dossage FDA Dossage Granisetron Hcl Dossage DMF Symptoms Dossage Generic Taj Pharmaceuticals Ltd.

active pharmaceutical ingredients suppliers pharmaceutical Granisetron Hydrochloride manufacturing pharmaceutical drugs pharmaceutical intermediates Granisetron Hydrochloride pharmaceutical chemicals pharmaceutical raw materials Granisetron Hydrochloride active pharmaceutical ingredients Granisetron Hydrochloride committee active pharmaceutical ingredients manufacturer Granisetron Hydrochloride Active Pharmaceutical Ingredients manufacturer Granisetron Hydrochloride exporter drug ingredients pharmaceuticals

Pharmaceuticals API Manufacturer Granisetron Hcl, Granisetron Hcl manufacturer India, Granisetron Hcl product, Granisetron Hcl products, Api preparation, Certificate of Analysis API manufacturer product, Granisetron Hcl anti ulcer product, Certificate of Origin COA Granisetron Hcl COS Granisetron Hcl, pharmaceutical generic, pharmaceutical drug, medical, Granisetron Hcl pharma healthcare, pharma patents, contract MSDS manufacturing Trader Granisetron Hcl pharma, generic pharma, HCL pharma MSDS pharmaceutical products, pharmaceutical formulations, generic import API, Granisetron Hcl expectorant Pharmaceutical GMP Method of analysis formulations manufacturer, Granisetron Hcl DMF drug master file pharmaceutical Anti Cancer active ingredient exporter from India, pharma Granisetron Hcl ingredients, api, HIV Granisetron Hcl, tablets, capsules, syrup & protein Granisetron Hcl powder, GMP of Plant api nutraceuticals, gynec products, ortho ingredients in India, oncology products, Granisetron Hcl gastroenterology products, buy, sell orthopaedic product, who gmp, cGMP, US FDA, Granisetron Hcl WHO, UKMHRA Approval

   PRODUCT LIST
   Home
   API >>>
   Pharmaceuticals API List
   Chemicals
   Manufacturing
   Product Development
   Product Search
   Agro Chemicals
   Custom Pharma Services
   Contact Us
 

api image Granisetron Hcl
















 












 

 

HOME >> API >> API List 2 >> Granisetron Hcl >> Dosage

CAS Number 107007-99-8

DOSAGE
Granisetron Hcl CAS Number 107007-99-8

Granisetron comes as a tablet and a solution (liquid) to take by mouth. Granisetron may be taken with or without food. When taken to prevent nausea and vomiting caused by chemotherapy, the first dose of Granisetron usually is taken 1 hour before chemotherapy is begunWhen taken to prevent nausea and vomiting caused by radiation, Granisetron is usually taken within 1 hour before treatment. Follow the directions on your prescription label carefully, and ask your doctor or pharmacist to explain any part you do not understand. Take Granisetron exactly as directed. Do not take more or less of it or take it more often than prescribed by your doctor. Granisetron injections are given by qualified health care professionals.

Chemotherapy-Induced Nausea and Vomiting
Adults

IV 10 mcg/kg (commonly rounded to nearest 1 mg), given up to 30 min before starting chemotherapy. Give only on day(s) of chemotherapy.
Chemotherapy-Induced Nausea and Vomiting
Adults

PO 1 mg twice daily. Give the first oral dose up to 1 h before chemotherapy and the second dose 12ߙh later. Give granisetron only on day(s) of chemotherapy. Alternately, a single 2 mg dose may be given up to 1 h before chemotherapy.
Children

IV 10 mcg/kg, given up to 30 min before starting chemotherapy. Give only on day(s) of chemotherapy.
Radiation-Induced Nausea and Vomiting
Adults

PO 2 mg once daily. Give the dose up to 1 h before radiation therapy. Give granisetron only on day(s) of radiation therapy.
Prevention/Treatment Postoperative Nausea and Vomiting
Adults

IV For prevention, use 1 mg undiluted, administered over 30 seconds, before induction of anesthesia or immediately before reversal of anesthesia. For treatment, use 1 mg undiluted, administered over 30 seconds, after surgery.

Information Associated with Product:
DRUG DESCRIPTION
DOSAGE >>
SIDE EFFECTS
PRECAUTIONS
INTERACTION
CONSUMER INFORMATION
 
 
PDF DOWNLOAD WORD DOCUMENT
Product Enquiry Product Quotation Sample Request Place Your Order  
Product Enquiry Product Quotation Sample Request Place Your Order  

Granisetron Hcl

Api Manufacturer,Export,Supplies,Manufacturing

Gabapentin

Gemcitabine Hcl

Glimepiride

Granisetron Hcl

Ibandronate Sodium

Imatinib Mesylate

Irbesartan

Irinotecan Hcl

Isradipine

Lamotrigine

Lercanidipine

Letrozole

Losartan Potassium

Loteprednol Etabonate

Magnesium Valproate

Meloxicam

Memantine Hcl

Mesalazine

Metamizol Magnesium

Metaxalone

Metformin Hcl

Metoprolol Tartrate

Mifepristone

Mirtazapine

Modafinil

Mometasone Furoate

Naltrexone Hcl

Netaglinide

Copyright © Taj Pharmaceuticals Ltd. | Privacy Policy | Terms & Conditions | Sitemap

Investor Relations    Feedback     Contact Worldwide    Sitemap

 

taj group logo
© 2004 - 2009 Taj Pharmaceuticals Limited . All rights reserved
Note:-We are committed to helping you find the right answers to your questions and concerns. However, this web site is not intended to give investment advice, promote the use of Taj Pharmaceuticals Ltd products or provide information on which to base medical treatment. If you have questions regarding any Taj Pharmaceuticals Ltd product or are experiencing a medical emergency, please consult your health care provider.
Additionally, contact information on this web site cannot be used to report adverse drug events. If you are a physician, please follow the procedures required by your country's regulations. Please choose one of the given options to contact us and we will respond to your inquiry as quickly as possible.